These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1023 related items for PubMed ID: 15122793

  • 41. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
    Bozdayi G, Türkyilmaz AR, Idilman R, Karatayli E, Rota S, Yurdaydin C, Bozdayi AM.
    J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237
    [Abstract] [Full Text] [Related]

  • 42. [The presence of nucleotide sequences of the hepatitis B virus in the serum of HBsAg-negative blood donors in Sardinia].
    Lai ME, Farci P, Puxeddu A, Figus A, Arnone M, Balestrieri A.
    Minerva Med; 1990 Apr; 81(4):283-6. PubMed ID: 2342654
    [Abstract] [Full Text] [Related]

  • 43. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH, Wu JC, Chang TT, Sheen IJ, Huo TI, Lee PC, Su CW, Lee SD.
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [Abstract] [Full Text] [Related]

  • 44. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y, Liu SL, Zhai XJ, Zhu FC, Pan H, Yu JX, Chen YZ, Xie YR, Zhang XY, Zhang HM, Li LJ, Wang H, Ruan B.
    J Med Virol; 2009 Sep; 81(9):1517-24. PubMed ID: 19626618
    [Abstract] [Full Text] [Related]

  • 45. Nucleic acid testing to detect HBV infection in blood donors.
    Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W.
    N Engl J Med; 2011 Jan 20; 364(3):236-47. PubMed ID: 21247314
    [Abstract] [Full Text] [Related]

  • 46. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P, Colson P, Coso D, Bories E, Charbonnier A, Stoppa AM, Auran T, Loundou A, Motte A, Ressiot E, Norguet E, Chabannon C, Bouabdallah R, Tamalet C, Gérolami R.
    J Viral Hepat; 2010 Nov 20; 17(11):807-15. PubMed ID: 20002298
    [Abstract] [Full Text] [Related]

  • 47. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC.
    Mikrobiyol Bul; 2007 Apr 20; 41(2):227-33. PubMed ID: 17682709
    [Abstract] [Full Text] [Related]

  • 48. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT.
    Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group.
    Hepatology; 2006 Dec 20; 44(6):1666-74. PubMed ID: 17133474
    [Abstract] [Full Text] [Related]

  • 49. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L, Strong DM, Tegtmeier G, Stramer S.
    Transfusion; 2008 Nov 20; 48(11):2315-22. PubMed ID: 18647367
    [Abstract] [Full Text] [Related]

  • 50. Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands.
    Utsumi T, Yano Y, Truong BX, Tanaka Y, Mizokami M, Seo Y, Kasuga M, Kawabata M, Hayashi Y.
    J Med Virol; 2007 Mar 20; 79(3):229-35. PubMed ID: 17245721
    [Abstract] [Full Text] [Related]

  • 51. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH, Ahn SH, Chung HY, Paik YH, Lee KS, Kim YS, Chon CY, Moon YM, Han KH.
    J Gastroenterol Hepatol; 2004 Aug 20; 19(8):847-53. PubMed ID: 15242485
    [Abstract] [Full Text] [Related]

  • 52. Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis.
    Yuasa R, Takahashi K, Dien BV, Binh NH, Morishita T, Sato K, Yamamoto N, Isomura S, Yoshioka K, Ishikawa T, Mishiro S, Kakumu S.
    J Med Virol; 2000 May 20; 61(1):23-8. PubMed ID: 10745228
    [Abstract] [Full Text] [Related]

  • 53. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.
    Transfusion; 2005 Aug 20; 45(8):1247-57. PubMed ID: 16078909
    [Abstract] [Full Text] [Related]

  • 54. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ.
    J Viral Hepat; 2006 Sep 20; 13(9):591-6. PubMed ID: 16907845
    [Abstract] [Full Text] [Related]

  • 55. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
    Launay O, Masurel J, Servant-Delmas A, Basse-Guérineau AL, Méritet JF, Laperche S, Sogni P, Rosenberg AR.
    J Viral Hepat; 2011 Oct 20; 18(10):721-9. PubMed ID: 21914087
    [Abstract] [Full Text] [Related]

  • 56. Two distinct types of hepatitis B virus core promoter variants in Yemeni blood donors.
    Sallam TA, Tong CY.
    J Med Virol; 2002 Nov 20; 68(3):328-34. PubMed ID: 12226818
    [Abstract] [Full Text] [Related]

  • 57. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.
    Awerkiew S, Däumer M, Reiser M, Wend UC, Pfister H, Kaiser R, Willems WR, Gerlich WH.
    J Clin Virol; 2007 Jan 20; 38(1):83-6. PubMed ID: 17134939
    [Abstract] [Full Text] [Related]

  • 58. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.
    J Gastroenterol Hepatol; 2008 Mar 20; 23(3):474-81. PubMed ID: 18318825
    [Abstract] [Full Text] [Related]

  • 59. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B, Mühlbacher A, Melchior W.
    J Clin Virol; 2005 Jan 20; 32(1):67-70. PubMed ID: 15572009
    [Abstract] [Full Text] [Related]

  • 60. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA, Stramer SL, Kuhns MC, Schlauder GG.
    Transfusion; 2012 Oct 20; 52(10):2201-8. PubMed ID: 22321072
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 52.